Patients with thyroid eye disease (TED) have a higher prevalence of low-risk human papillomavirus (HPV) diagnosed before ...

Gastrointestinal side effects are the main reason people stop treatment. Typical issues include nausea, vomiting, constipation and diarrhoea. The review explicitly discusses the impact of side effects ...

According to our experts, this leads to symptoms including: ...

"In addition to thyroid dysfunction, there are many factors that can affect our energy levels, weight, and mood such as sleeping and eating patterns, stress levels, medications, and other medical ...

- Priority Review designation is granted to applications for drugs that, if approved, would be a significant improvement in the safety or effectiveness of treating a serious condition - - Veligrotug ...

TED is an autoimmune disorder distinct from Graves disease, affecting individuals with varying thyroid states and often misdiagnosed, especially in women. Symptoms of TED, such as pain and double ...

Two phase 3 trials evaluating a subcutaneous (SC) formulation of efgartigimod (efgartigimod alfa and hyaluronidase-qvfc [PH20]), a neonatal Fc receptor blocker, for the treatment of moderate to severe ...

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders GenSci to receive $70 million ...

Argenx SE (NASDAQ: ARGX) on Monday announced it would discontinue the Phase 3 UplighTED studies evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with ...

(RTTNews) - Argenx SE (ARGX ARGX.BR) announced on Monday that it is discontinuing its Phase 3 UplighTED studies evaluating Efgartigimod PH20 SC in adults with moderate to severe thyroid eye disease, ...

While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoimmune indications, not every shot in the clinic is destined to land. Now, facing that fact in thyroid eye ...